Streetbeat News

CLVRW

Clever Leaves Holdings Inc

Employees

280

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

clever leaves, a colombian company fully-licensed, will become the world’s largest grower with over 10mm+ ft2 of cultivation capacity by 2023, the largest extractor with pharmaceutical grade and gmp certified processing facilities, and the lowest cost operator in cannabis exports. one of the first colombian license holders in the medical cannabis industry. a company positioned to become a leader in the global market with a differentiated business model and strong positioning with regulators, physicians, and other relevant players. developing key capabilities to win in the new space of the medical cannabis industry with a highly experienced and respected team.

Open

0.03

Mkt cap

42K

Volume

1.1K

High

0.03

P/E Ratio

-0.01

52-wk high

0.05

Low

0.03

Div yield

N/A

52-wk low

0.00

Trading for CLVRW was halted and then resumed at 4:40:00 PM ET, with updates on quotation resumption, news, and resumption times provided.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 8:40 pm

Trading for CLVRW was halted at 4:06:44 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the stock is released.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 8:07 pm

Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) reported a 6% revenue increase for the full year ended December 31, 2023, with a notable 39% rise in cannabinoid revenue. The fourth quarter saw a 5% revenue increase to $4.6 million, driven by the cannabinoid segment's 29% growth. Operational improvements included a significant increase in harvest volume. The company also completed the sale of its Non-Cannabinoid Herbal Brands Business for $8.02 million on March 21, 2024, as part of its strategic focus on core operations.

Portfolio Pulse from Nicolás Jose Rodriguez

April 02, 2024 | 1:24 am

Tilray and Curaleaf are expanding their presence in Europe, capitalizing on the rapidly growing cannabis market. Curaleaf announced a new supply agreement in the Czech Republic, while Tilray received approval for its first medical cannabis extract in Portugal. The European cannabis market surpassed €2 billion in 2023, with Germany, Czech Republic, Switzerland, and the Netherlands leading regulatory developments. The Benzinga Cannabis Capital Conference in Florida will further discuss these market dynamics.

Portfolio Pulse from Jelena Martinovic

March 14, 2024 | 2:58 pm

Clever Leaves Holdings Inc. partners with Paradise Seeds to develop cannabis cultivars in Colombia, aiming to expand its global footprint. Avicanna Inc. receives approval for Trunerox to treat epilepsy in Colombia, marking a significant milestone. However, Colombian Congress shelved a bill for regulating adult cannabis use, reflecting legislative divisions. This regulatory landscape impacts companies like Clever Leaves, PharmaCielo Ltd, and Khiron Life Sciences Corp, as they navigate the evolving market.

Portfolio Pulse from Nicolás Jose Rodriguez

February 14, 2024 | 4:21 pm

Colombia's Senate has postponed the consideration of a bill to legalize marijuana, despite the measure having previously advanced through the Chamber of Representatives and a Senate committee. President Gustavo Petro criticized the Senate's decision, stating it would benefit illegal drug trade and increase violence. If the reform is to be pursued, the legislative process must restart next year. Cannabis companies like Clever Leaves Holdings Inc. (CLVR), PharmaCielo Ltd. (PCLOF), and Khiron Life Sciences Corp. (KHRNF) could benefit from such policy changes. The article also promotes Benzinga PotProfits, a service for cannabis stock investment opportunities.

Portfolio Pulse from Jelena Martinovic

December 15, 2023 | 1:21 pm

Clever Leaves Holdings (NASDAQ:CLVR) (NASDAQ:CLVRW) has undertaken a 30-to-1 share consolidation to maintain its listing on the NASDAQ amid declining share prices. The company also reported a $3.6 million net loss for the quarter ending June 30, with revenues nearing $5 million. Shares of CLVR were down 9.85% at $4.12 per share after the bell on Monday evening.

Portfolio Pulse from Joana Scopel

August 28, 2023 | 10:10 pm

Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) has announced that its Colombian cannabis flower is now available to medical patients in Australia through a partnership with Australian Natural Therapeutics Group (ANTG). The products are under ANTG’s “Global Selects” brand portfolio. The news has led to a 7.22% increase in Clever Leaves shares, trading at $0.2198 per share.

Portfolio Pulse from Vuk Zdinjak

July 26, 2023 | 1:40 pm

Clever Leaves Holdings Inc. has sold its cannabis processing facility in Portugal to Terra Verde, an affiliate of Curaleaf Holdings, Inc. The sale, which includes lab and processing equipment, was closed for approximately $2.7 million. The proceeds are expected to improve Clever Leaves' cash position and will be used for working capital and general corporate purposes. Clever Leaves plans to wind down its Portuguese operations and consolidate its cultivation and manufacturing processes in Colombia.

Portfolio Pulse from Vuk Zdinjak

July 05, 2023 | 12:39 pm

Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals to supply EU-GMP certified CBD extracts from Colombia to its operations in Portugal. The first shipments have been completed, and Clever Leaves will continue to supply pharmaceutical-grade APIs and CBD extracts for patients across Europe.

Portfolio Pulse from Vuk Zdinjak

May 25, 2023 | 1:44 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.